Skip to main content

Bryn Inc.

corporate_fare Company Profile

Bryn Inc.

BRRN·OTC·Trade & Services·CIK 0001397795

Byrn, Inc. is a Nevada corporation formed in April 2011 as an emerging healthcare knowledge solution company. The company's initial purpose was to transform health and healthcare by developing a standard for measuring clinical performance and outcomes. Byrn, Inc. developed medical software that included tools and analytics designed to reduce costs while improving clinical performance, outcomes, predictive insight, and evidence-based best clinical processes. The company was dormant from March 22, 2013, through December 26, 2019. On December 27, 2019, Custodian Ventures, LLC was appointed as the custodian of Byrn, Inc. by the Nevada Court. On December 31, 2019, Mr. Lazar became the sole Director and Officer, serving as President, Treasurer, and Secretary. On April 5, 2020, Mr. Lazar was granted 10,000,000 preferred shares with super-voting rights of 21,000,000,000 common shares, with each preferred share convertible into 250 shares of common stock. On September 10, 2020, the company filed a Certificate of Designation in Nevada, changing the conversion and voting rights of its Series A preferred stock, $.001 par value per share, to 250 for each one (1) share of Series A preferred stock. On September 23, 2020, 10,000,000 shares of Series A Convertible Preferred Stock, $0.001 par value per share, were transferred from Custodian Ventures, LLC to FiveT Capital Holding AG in a private transaction.

Bryn Inc. (OTC:BRRN) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 5 items for BRRN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-16, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for BRRN spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Bryn Inc. Announces 1-for-100,000 Reverse Split and Name Change to MEDO Technologies
  • Bryn Inc. Q2 2026: Going Concern Deepens as Related-Party Debt Swells and Internal Controls Flagged
  • Bryn Inc. Details Change of Control, New AI-Driven Pharma Strategy, and Ongoing Going Concern
  • New Owners Take Control of Bryn Inc., Appointing Experienced CEO and CFO
  • Auditor Raises Substantial Doubt on Byrn, Inc.'s Ability to Continue as Going Concern Amidst Zero Operations and Related Party Dependence
Browse all tickers starting with B →
$0.021
52-week range · as of 2026-09-16 $0.000001 – $9.9
Market cap
$9.45M
Volume
113.5K (12.2× avg)
3-mo avg 9.3K
Last traded · 2026-09-24

show_chartPrice Chart

Loading chart...

feed BRRN - Latest Insights

BRRN
Sep 16, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3636
Real-time Price: $0.021 info
Change: Reverse Stock Split info
Market Cap: $9.45M info
BRRN
Aug 14, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1322
Real-time Price: $0.021 info
Change: Reverse Stock Split info
Market Cap: $9.45M info
BRRN
May 19, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.210
Real-time Price: $0.021 info
Change: Reverse Stock Split info
Market Cap: $9.45M info
BRRN
May 11, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.2999
Real-time Price: $0.021 info
Change: Reverse Stock Split info
Market Cap: $9.45M info
BRRN
Apr 02, 2026, 3:57 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.0666
Real-time Price: $0.021 info
Change: Reverse Stock Split info
Market Cap: $9.45M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets